RHÖN-KLINIKUM AG Reports Stable First Half of 2025 Results

RHÖN-KLINIKUM AG announced solid financial results for the first half of 2025, with revenues increasing by 7.5% to EUR 883.5 million. The rise was bolstered by a moderate uptick in patient numbers. Despite ending legislative relief for high energy prices, the company reported stable EBITDA but saw a decrease from EUR 49.1 million in 2024 to EUR 46.7 million.

The consolidated profit declined to EUR 14.7 million, affected by financing results. The equity ratio remained stable at 71.3%. The company confronted cost structure challenges, geopolitical risks, high purchasing prices, and wage increases. Nonetheless, the management remains focused on navigating market conditions.

Looking ahead, RHÖN-KLINIKUM AG holds its revenue forecast for 2025 at EUR 1.7 billion, with EBITDA expected between EUR 110 million and EUR 125 million, amid a regulatory challenging environment.